Robert Lakin

Robert Lakin

InvestorPlace Contributor

A journalist — both writer and editor — Robert has covered markets and economies for more than 20 years. His previous gigs include Bloomberg News, where he was emerging markets editor in Tel Aviv, McKinsey & Co. and McDonald & Company Investments, where he was equities research editor.

His deep experience includes covering startups, emerging markets, financial services, and capital markets.

He writes a Substack newsletter, TLV Strategist, which covers the Israel business scene.

Recent Articles

HOL Stock: Holicity Shares Rocket on Astra Space SPAC Merger

By Robert Lakin, InvestorPlace Contributor

SPACs and space are the hot topics fueling blank-check firm Holicity's shares this morning. HOL stock will become ASTR stock after a merger.

Ethereum Price Predictions: Will ETH Set a New Record After Reddit Rally?

By Robert Lakin, InvestorPlace Contributor

Ethereum price predictions are calling for the crypto to hit a new all-time high as Robinhood restrictions prompt interest in DeFi options.

NIO Stock: Why Red-Hot Nio Shares Are on the Move Today

By Robert Lakin, InvestorPlace Contributor

NIO stock looks poised to reverse last week's losses after the Chinese EV maker reveal record sales in January.

THCB Stock: Tuscan Holdings Shares Surge on Microvast SPAC Merger News

By Robert Lakin, InvestorPlace Contributor

Tuscan Holdings found a partner in EV battery maker Microvast, sending the SPAC's shares surging. THCB stock will soon be trading as the newly listed MVST stock.

NVAX Stock: Why Novavax Shares Are Shooting Higher Today

By Robert Lakin, InvestorPlace Contributor

Novavax is in the spotlight as a U.K. study showed its Covid-19 vaccine to be 89% effective. As with other biopharma stocks before it, NVAX stock surged on the news.

Load More